Active ingredientMometasone FuroateCat. No. P-M162-001CAS 83919-23-7Family · Pharmaceutical analytical standards
Mometasone
A synthetic corticosteroid patented in 1981 and in use since 1987: it is applied to the skin for eczema and psoriasis, sprayed into the nose for allergic rhinitis and nasal polyps, and inhaled to prevent asthma. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?Mometasone itself has never been marketed: it is always used as its ester, mometasone furoate. Besides its corticosteroid action, it is also a very potent activator of the progesterone receptor.
Go to the active ingredient →Active ingredientMometasone FuroateCat. No. P-M162-001CAS 83919-23-7
Pharmacopoeial impurityMometasone Furoate EP Impurity ACat. No. P-M162-002CAS 83880-65-3
Pharmacopoeial impurityMometasone Furoate EP Impurity BCat. No. P-M162-003CAS 223776-49-6
Pharmacopoeial impurityMometasone Furoate EP Impurity CCat. No. P-M162-004CAS 1305334-31-9
Pharmacopoeial impurityMometasone Furoate EP Impurity DCat. No. P-M162-005CAS 83881-09-8
Pharmacopoeial impurityMometasone Furoate EP Impurity ECat. No. P-M162-006CAS 1370190-33-2
Pharmacopoeial impurityMometasone Furoate EP Impurity FCat. No. P-M162-007CAS 1305334-30-8
Pharmacopoeial impurityMometasone Furoate EP Impurity GCat. No. P-M162-008CAS 105102-22-5
Pharmacopoeial impurityMometasone Furoate EP Impurity HCat. No. P-M162-009CAS 148596-90-1
Pharmacopoeial impurityMometasone Furoate EP Impurity ICat. No. P-M162-010
Pharmacopoeial impurityMometasone Furoate EP Impurity JCat. No. P-M162-011CAS 1370190-55-8
Pharmacopoeial impurityMometasone Furoate EP Impurity KCat. No. P-M162-012CAS 4647-20-5
Pharmacopoeial impurityMometasone Furoate EP Impurity MCat. No. P-M162-013CAS 57780-86-6
Pharmacopoeial impurityMometasone Furoate EP Impurity NCat. No. P-M162-014CAS 352315-75-4
Pharmacopoeial impurityMometasone Furoate EP Impurity OCat. No. P-M162-015CAS 24916-91-4
Pharmacopoeial impurityMometasone Furoate EP Impurity PCat. No. P-M162-016
Pharmacopoeial impurityMometasone Furoate EP Impurity QCat. No. P-M162-018CAS 83881-08-7
Pharmacopoeial impurityMometasone Furoate EP Impurity RCat. No. P-M162-019CAS 1370190-08-1
Pharmacopoeial impurityMometasone Furoate EP Impurity SCat. No. P-M162-020CAS 2231764-75-1
Pharmacopoeial impurityMometasone Furoate EP Impurity TCat. No. P-M162-021
Isotopically labelledMometasone Furoate-d3Cat. No. P-M162-023
Isotopically labelledMometasone-d3Cat. No. P-M162-024
Isotopically labelledMometasone-d6Cat. No. P-M162-025
Impurity6-alpha-Hydroxy Mometasone FuroateCat. No. P-M162-026CAS 134429-33-7
Impurity6-beta-Hydroxy Mometasone FuroateCat. No. P-M162-027CAS 132160-74-8
ImpurityMometasone Impurity 1Cat. No. P-M162-029
ImpurityMometasone Impurity 2Cat. No. P-M162-030CAS 201601-32-3
ImpurityMometasone Impurity 3Cat. No. P-M162-031CAS 722495-06-9
ImpurityMometasone Impurity 4Cat. No. P-M162-032
ImpurityMometasone Impurity 5Cat. No. P-M162-033
ImpurityMometasone Impurity 6Cat. No. P-M162-034
ImpurityMometasone Impurity 8Cat. No. P-M162-036CAS 1404070-67-2
Active ingredientMometasone furoate monohydrateCat. No. P-M162-037CAS 141646-00-6
ImpurityMometasone-17,20-DifuroateCat. No. P-M162-038No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceMometasone furoate CRSEDQM code M2900000Family MometasoneReference substanceMometasone furoate monohydrate CRSEDQM code Y0001981Family MometasoneNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.